Outsourcing Sterile Compounding: Proposed Regulations and Safety Considerations

Outsourcing Sterile Compounding: Proposed Regulations and Safety Considerations

Item #:

100080WBCD

Price/ea:

$215.00

Product Image Gallery:

Outsourcing Sterile Compounding: Proposed Regulations and Safety Considerations

 

 

Program Overview:

Sterile compounded medications are used in almost every hospital in the country. Often such products are prepared onsite, but increasingly hospital pharmacies are choosing to outsource the preparation of these products to external admixtures service providers. Recently, a national and deadly outbreak of meningitis linked to products prepared by a compounded pharmacy in Massachusetts has refocused attention on the significant gaps in regulatory authority over these entities. Health-system pharmacies are thus challenged to ensure safety with the purchase of outsourced products. Oversight through federal and state regulations had been proposed to close these "gaps," and therefore improve the safety of sterile compounded preparations. Join our speakers as they describe existing laws and regulations and the anticipated changes associated with proposed state and federal legislation. In addition, accreditation requirements for hospitals using outsourced compounded sterile preparations will be discussed. Speakers will also discuss current and proposed regulation accreditation requirements for hospitals that use compounded pharmacies, in-house preparation versus outsourcing, and considerations when selecting an outsourced pharmacy. 

 

Intended Audience:

Interdisciplinary teams are encouraged to attend together:

• Pharmacy Leadership
• Pharmacists and Technicians who compound sterile preparations
  
• Patient and Medication Safety Officers
• Hospital Leadership
• Quality and Risk Management Leaders
• Pharmacy Purchasing Agents/Inventory Coordinators
  

Objectives:

Following completion of the webinar, participants will be able to:

• Identify at least three key issues that may affect hospitals and health-systems as a result of proposed federal and state legislation related to sterile compounding
• Describe at least three current requirements related to sterile compounding under state laws and regulations, and accreditations standards
• Compare and contrast important considerations when deciding whether to provide compounded sterile preparations from in-house versus outsourced providers
  
• List criteria that can be used when selecting an outsourcer for sterile compounding services

Moderator:

Matthew Fricker, Jr. MS, RPh, FASHP

Program Director

Institute for Safe Medication Practices

Horsham, PA

Speakers:

Darryl Rich, PharmD, MBA, FASHP

Medication Safety Specialist

Institute for Safe Medication Practices

Horsham, PA

Tom Van Hassel, RPh, MPA
Director of Pharmacy
Yuma Regional Medical Center
President, Arizona Board of Pharmacy
Yuma, AZ

CONTINUING EDUCATION

This webinar is approved for 1.5 hours of Pharmacy Continuing Education and 1.0 hour of Nursing Continuing Education. There is no additional charge for continuing education credits for this webinar.